Article info

Download PDFPDF

Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK?

Authors

  • Sandeep Dhanda Drug Safety Research Unit, Southampton, Hampshire, UKSchool of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, Hampshire, UK PubMed articlesGoogle scholar articles
  • Vicki Osborne Drug Safety Research Unit, Southampton, Hampshire, UKSchool of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, Hampshire, UK PubMed articlesGoogle scholar articles
  • Elizabeth Lynn Drug Safety Research Unit, Southampton, Hampshire, UKSchool of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, Hampshire, UK PubMed articlesGoogle scholar articles
  • Saad Shakir Drug Safety Research Unit, Southampton, Hampshire, UKSchool of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, Hampshire, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Sandeep Dhanda, Drug Safety Research Unit, Southampton SO31 1AA, UK; sandeep.dhanda{at}dsru.org
View Full Text

Citation

Dhanda S, Osborne V, Lynn E, et al
Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK?

Publication history

  • Accepted September 21, 2020
  • First published October 21, 2020.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.